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Estrogen receptor (ER, alpha isoform) is a 67 kDa zinc finger transcription factor that plays a
fundamental role in both normal reproductive gland development and breast carcinogenesis,
and also represents a critical molecular target for breast cancer therapy. We are investigating
the structural consequences of chemical exposures thought to modify essential zinc finger
cysteine residues in human ER. The current study employs mass spectrometry to probe ER
zinc finger structural changes induced by a redox-reactive vitamin K3 analog, menadione; a
commonly used cysteine alkylator, iodoacetic acid; and a thiol alkylating fluorophore,
monobromobimane. Although they are slower to react, the sterically bulkier reagents,
monobromobimane and menadione, effectively alkylate the most susceptible ER zinc finger
cysteine sulfhydryl groups. Menadione arylation results first in Michael addition of the
hydroquinone followed by rapid oxidation to the corresponding quinone, evidenced by a 2 Da
mass loss per cysteine residue. Mass spectrometric analysis performed under MALDI
conditions reveals both hydroquinone and quinone forms of arylated menadione, whereas
only the quinone product is detectable under ESI conditions. Tandem mass spectrometry of a
synthetic peptide encompassing the C-terminal half of the structurally more labile second zinc
finger of ER (ZnF2B) demonstrates that the two nucleophilic thiols in ZnF2B (Cys-237, Cys-240)
are not chemically equivalent in their reactivity to bromobimane or menadione, consistent
with their unequal positioning near basic amino acids that affect thiol pKa, thereby rendering
Cys-240 more reactive than Cys-237. These findings demonstrate important differential
susceptibility of ER zinc finger cysteine residues to thiol reactions. (J Am Soc Mass Spectrom
2005, 16, 2017–2026) © 2005 American Society for Mass SpectrometryThe 67 kDa human estrogen receptor (ER, alphaisoform) represents a critical transcription factorprotein that mediates estrogen induced gene ex-
pression essential for normal reproductive gland devel-
opment, the overexpression of which also drives the
development of most human breast cancers and serves
as the molecular target for all forms of breast cancer
endocrine therapy [1, 2]. Oxidative stress or chemical
interference with either of the two Cys4-type zinc finger
structures located within the ER DNA-binding domain
(ER-DBD) may prevent its ability to directly bind DNA
in a sequence-specific manner without impairing its
ability to modulate gene expression by protein–protein
interactions with other DNA-bound transcription fac-
tors [3, 4]. Given the susceptibility of all zinc finger
transcription factors to oxidative stress, recent studies
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doi:10.1016/j.jasms.2005.08.009have focused on the reactivity of zinc finger structures
to various electrophilic compounds that selectively tar-
get nucleophilic residues, such as the zinc coordinating
cysteine thiols found in the ER-DBD [4 –7].
Evidence from computational and tertiary structural
analysis by nuclear magnetic resonance (NMR) indi-
cates that the second (C-terminal) zinc finger of ER
(ZnF2) is loosely structured and, therefore, likely more
labile [7–9], potentially explaining why the cysteine
residues of ER ZnF2 appear more susceptible to oxida-
tive stress and chemical attack than those in the more
N-terminal zinc finger of ER [10]. While it has been
proposed that chemical modification of ER zinc fingers
may inhibit the growth of some ER expressing cancers
by preventing ER dimerization and transactivation [5,
6], it has also been shown that exposure to electrophilic
quinones such as those generated during estrogen me-
tabolism can induce tumorigenesis via their redox cy-
cling or direct structural attack of nucleic acids and
proteins, including ER [11–15]. Of particular interest,
protein-quinone conjugates can theoretically become
molecular platforms for continued intracellular quinone-
hydroquinone cycling, local generation of reactive oxy-
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2018 ATSRIKU ET AL. J Am Soc Mass Spectrom 2005, 16, 2017–2026gen species (ROS), and chronic propagation of oxidative
damage to surrounding macromolecules.
The vitamin K analog menadione (K3), capable of
both redox cycling and arylating nucleophilic substrates
by Michael addition, has been extensively studied as a
model stress inducing quinone [15]. In addition to
activating intracellular oxidant stress pathways, mass
spectrometry (MS) analysis has recently revealed that
brief exposure to K3 can result in arylation of the
singular cysteine residue (Cys110) within histone
H3.3/H3 [16]. Earlier studies had shown that brief
treatment of ER-expressing breast cancer cells in culture
with K3 also results in irreversible functional loss of
ER-DNA binding [3], presumably due to the Michael
addition of either the quinone or hydroquinone form of
K3 to one or more nucleophilic groups within the
ER-DBD [17, 18]. However, analytical and structural
studies of chemical modifications within the ER-DBD
remain challenging, given the much lower abundance
of endogenous ER relative to proteins like histone
H3.3/H3, even when ER is markedly overexpressed in
Figure 1. ER-DBD showing the N-terminal and C-terminal zinc
fingers. Double protease digestion with endoproteinase Lys-C and
Asp-N yields four diagnostic zinc finger peptides: ZnF1A, 1B, 2A,
and 2B. The synthetic peptide ZnF corresponds to residues 231–
244.
Table 1. Chemical structures of alkylating/arylating reagents u
Reagent Structure
Iodoacetic acid (IAA) ICH2COOH
Bromobimane (BrB)
Menadione (k3)human breast cancer cells. Biochemical methods such as
the zinc ejection assay have been used to indirectly
assess the lability of ER zinc fingers to electrophilic
attack [5]; but we believe that direct MS assessment will
ultimately be required to measure and precisely iden-
tify chemical modifications within the DBD of endog-
enously expressed ER.
As an important step towards this aim, we have
sought to develop and optimize a mass spectrometry
based technique to fingerprint in vitro covalent changes
occurring in the zinc fingers of human ER protein. The
current study employed human recombinant ER pro-
tein and synthetic ER zinc finger peptides to develop
MS and tandem MS (MS/MS) methods capable of
probing the ER-DBD for structural changes induced by
various thiol-reactive agents. To specifically assess ary-
lation products formed by quinones like K3, we ex-
tended our previously described protocol involving
double enzymatic digestion of ER (Figure 1), followed
by liquid chromatography-electrospray ionization (LC-
ESI) MS [19]. As shown in Table 1, in addition to K3,
other thiol-reactive agents used to treat ER protein or
synthetic peptides included iodoacetic acid (IAA) and
monobromobimane (BrB). IAA is typical of several
standard alkylating reagents widely used in protein
chemistry and MS studies to protect cysteine thiols
against oxidation or uncontrolled alkylation, as seen
during polyacrylamide gel electrophoresis [20]. The
fluorescent agent BrB is less well known in MS studies;
similar in size to K3, its steric bulkiness has been used
to map drug binding sites in proteins [21]. While BrB
fluorescence is a valuable property for monitoring over-
all thiol oxidation status in proteins, the existence of
four cysteine residues outside the ER-DBD (which itself
contains nine cysteines, as shown in Figure 1), renders
total BrB fluorescence noninformative with respect to
ER-DBD thiol status. To probe for position-specific
cysteine reactivity within an ER-DBD zinc finger, we
this study
Peptide conjugate
Nominal mass
change per Cys
RS-CH2COOH 58 Da
190 Da
172 Dased in
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passing the C-terminal half of ER ZnF2 (Figure 1).
Materials and Methods
Materials
2-Methyl 1,4-naphthoquinone (K3), 3-bromomethyl-
2,5,6-trimethyl-pyrazolo[1,2-a]pyrazole-1,7-dione (BrB),
iodoacetic acid (IAA), dithiothreitol (DTT), 2,4-dihy-
droxybenzoic acid (DHB), -cyano-4-hydroxy cinnamic
acid (HCCA), formic acid, and trifluoroacetic acid
(TFA) were purchased from Sigma-Aldrich (St. Louis,
MO). Acetonitrile, HPLC-grade, was acquired from
Fisher Scientific (Pittsburgh, PA). Two versions of the
synthetic zinc finger peptide (KNRRKSCQACRLRK)
prepared by AnaSpec Inc. (San Jose, CA) with free
cysteines (ZnF) and with cysteines blocked by acet-
amidomethyl groups (ZnF·acm2), respectively, were
dissolved in water at 5 mg/ml and stored at 20 °C for
subsequent use. The recombinant  isoform of ER (67
kDa) was obtained from Pan Vera (Madison, WI).
Monitoring ER Oxidation Status by BrB Labeling
Briefly, the strategy involved titration of ER (14 pmol) with
the thiol-oxidant, diamide [(CH3)2NCONNCON(CH3)2]
(100 M), as a function of time (15–120 min) to induce
cysteine-disulfide oxidation at room-temperature. This was
followed by labeling of any remaining free cysteine thiols
with the fluorescent agent BrB (3 mM) in the dark at 40 °C for
60 min. The labeled protein was then heated with Laemmli
sample buffer (95 °C/5 min), loaded onto a gel (SDS-PAGE)
and separated at 200 V for 45min. The gel was subsequently
fixed and washed in 10% acetic acid/40% methanol (vol/
vol), followed by visualization and densitometric analysis of
fluorescent bands on the gel (Figure 2). The decrease in
fluorescence intensity was attributed to cysteine-disulfide
formation (oxidation) before BrB labeling of the remaining
Figure 2. 1D gel showing fluorescent bands of recombinant ER
visualized under UV light (365 nm) produced by titration of ER
(10 pmol) with the thiol-specific oxidant, diamide, followed by
labeling with BrB and densitometry. Lane 1, no diamide; lanes 2 to
5, diamide treatment for 15, 30, 60, and 120 min respectively.free thiol groups.Alkylation Reactions and Kinetic Studies
A group of alkylation reaction experiments was pre-
ceded by complete reduction of all cysteine-disulfides
in the synthetic peptide by the addition of 20 l DTT (10
mM) to 80 l of the peptide solution (100 pmol/l) and
heating for 60 min at 40 °C. Aliquots (5 l) of the
peptide solution (78 pmol/l) were transferred into
separate siliconized tubes and diluted to 40 l with
either formic acid (0.1% vol/vol), distilled water, or
ammonium bicarbonate (25 mM) at pH 2.8, 7.4 or 9.0,
respectively. Excess alkylating agent was added to a
final concentration of 5 mM and the reaction mixture
was incubated at 37 °C in the dark. Aliquots (4 l) of the
reaction mixture were taken at specific time intervals
between 0 and 120 min, diluted tenfold in 0.1% formic
acid to bring the peptide concentration to10 pmol/l,
and immediately mixed (1:1 vol/vol) with the MALDI
matrix (DHB) and analyzed byMALDI-TOF. The rate of
each reaction was monitored by following the rate of
disappearance of the unconjugated peptide, assuming
that MALDI peak intensities were approximately pro-
portional to concentration. A pseudo-first-order rate
constant (k, s1) for reaction with each of the selected
reagents was determined experimentally from the slope
of a plot of natural logarithm (ln) of the percentage of
unreacted peptide versus incubation time.
In Vitro Chemical Modification
of Recombinant ER
Alkylation experiments involving ER with either IAA,
BrB, or K3 were carried out according to our previously
described double protease digestion protocol [19]. A
solution of ER (5 pmol) was treated with each of the
respective alkylating/arylating agents to a final concen-
tration of 4 mM in separate tubes and incubated at 37 °C
in the dark for 90 min. Incubation reactions of ER with
K3 were performed in slightly acidified medium with
acetic acid (0.1% vol/vol). The reaction mixture was
then diluted tenfold with ammonium bicarbonate (pH
8, 25 mM), followed by a 3 h digestion with endopro-
teinase Lys-C (360 ng) from Lysobacter enzymogenes
(Roche Diagnostics, Indianapolis, IN). The second en-
zyme, endoproteinase Asp-N (140 ng), derived from
Pseudomonas fragi (Roche) was added and digestion
allowed to continue for 3 h at 37 °C in the dark. The
resulting peptide mixture was desalted using a C-18
ZipTip with a 0.6 l bed volume (Millipore, Bedford,
MA). Peptides were eluted with 25 l 60:40 vol/vol
acetonitrile/0.1% vol/vol formic acid, concentrated by
Speedvac to near dryness and reconstituted in 10 l
formic acid (0.1% vol/vol) for subsequent analysis by
MALDI-TOF and LC-ESI-MS/MS.
MALDI-TOF Analysis
MALDI-TOF was carried out using a Voyager-DE
STR instrument (Applied Biosystems, Framingham,
2020 ATSRIKU ET AL. J Am Soc Mass Spectrom 2005, 16, 2017–2026MA) equipped with a N2 laser (337 nm). Equal
volumes (1:1 vol/vol) of the peptide reaction mixture
containing the alkylation reagent in formic acid (0.1%
vol/vol), distilled water, or ammonium bicarbonate
were mixed with either DHB or HCCA matrix and
manually spotted onto the MALDI target plate. Mass
spectra were recorded in positive ion reflector mode,
100 shots being accumulated for each spectrum. The
instrument was calibrated using an external apomyo-
globin standard. Spectra were smoothed by applying
a Gaussian function and the baseline was corrected.
Semiquantitation of peptides (unalkylated and alky-
lated adducts) was achieved using the manufactur-
er’s software for integration of the monoisotopic (mi)
peaks (Applied Biosystems, Foster City, CA). To
determine relative abundances, the peak height of the
unconjugated peptide was expressed as a percentage
of the sum of the peak heights of the unconjugated
and conjugated peptide species in each spectrum.
Peptide maps of ER were generated for double pro-
tease digestions (Lys-C and Asp-N) of the untreated
and treated (IAA, BrB, or K3) protein. MALDI-TOF
spectra generated using 1:1 vol/vol mixture of the
digest and HCCA matrix were internally calibrated
using autolysis peaks of endoproteinase Lys-C. Using
the MS-FIT search engine in ProteinProspector v 4.0.5
(University of California, San Francisco), m/z values
for diagnostic peptides in the control and treated
samples of ER were compared to identify modified
cysteine residues.
LC-ESI-MS/MS Analysis
LC-ESI-MS/MS analysis was carried using a QSTAR
Pulsar mass spectrometer (MDS Sciex, Concord, On-
tario, Canada) operated in the positive-ion mode with
a nano-electrospray needle voltage of 2300 V. Sam-
ples (2 l) were injected using a Famos autosampler
(LC Packings) and separation achieved using a 75 m
 150 mm PepMap reversed-phase column (5 m
particle size) (LC Packings, Sunnyvale, CA). Elution
of peptides from the column was carried out with a
binary solvent system: solvent A (0.05% formic acid
in 98% H2O/2% acetonitrile) and solvent B (0.05%
formic acid in 2% H2O/98% acetonitrile) at a flow
rate of 300 nl/min. The gradient was 2% solvent B
from 0–5 min, followed by 2–70% solvent B from 5–55
min. MS and tandem MS data were recorded contin-
uously based on a 4-s cycle time. Within each cycle,
MS data were accumulated for 1 s, followed by 3 s
MS/MS acquisitions. Nitrogen gas was used for
collision dissociation and collision energy automati-
cally ramped with respect to m/z value of selected ion.
Precursor ion selection for CID was based on the
creation of an inclusion list of anticipated precursor
ions.Results
Fluorescence Detection of ER Thiol Status
The fluorescent property of thiol-bound BrB allows its
arylation of ER to be monitored by protein electro-
phoresis and fluorimetry, as shown in Figure 2. Recom-
binant ER protein was first oxidized with diamide for
0–120 min and then exposed to excess BrB to quench
the reaction and allow for BrB reaction with remaining
unreacted ER cysteine residues. After separation by
SDS-PAGE and fluorescence visualization, the BrB flu-
orescence intensity of the intact 67 kDa ER protein band
measured by densitometry showed the expected pro-
gressive loss in ER fluorescence with increasing dia-
mide preoxidation time, indicating a proportional loss
in ER free thiols. However, the residual fluorescence
and plateau shape of the ER fluorescence loss by 120
min, despite treatment with diamide at a dose known to
completely eliminate ER DNA binding [3], suggests that
BrB may either alkylate other ER nucleophilic residues
not susceptible to diamide or otherwise not serve as a
specific indicator of ER thiol oxidation status. Thus,
more precise MS techniques were used to monitor
alkylation of ER by BrB as well as by two other known
thiol reactants, IAA and K3, not readily monitored by
fluorescence. These chemical reactions were first stud-
ied by using a synthetic peptide substrate, ZnF, repre-
senting the C-terminal half of the second ER zinc finger,
and then confirmed by using recombinant ER protein as
substrate (Figure 1).
MS Analysis of ER Zinc Finger Peptide
As ZnF contains two cysteine residues, three possible
molecular ions were anticipated for each reaction,
representing unreacted (0), singly-conjugated (1), and
doubly-conjugated (2) peptides. Representative
MALDI-TOF spectra generated from 1 h incubations of
ZnF with each reagent are shown in Figure 3, all
reactions being carried out at pH 7.4 and 37 °C. Figure
3a illustrates the ZnF reaction products formed with
IAA. As anticipated, the doubly-alkylated species gave
a protonated molecular ion at m/z 1863, which consti-
tuted the most intense peak. The mono-alkylated pep-
tide ion (m/z 1805) represented the second most abun-
dant ion, and the unreacted peptide ion (m/z 1747) was
not readily detectable. The presence of a weak peak at
m/z 1921 suggested formation of triply (3) alkylated
adducts of IAA, possibly resulting from additional IAA
reaction with an -amino group. Since ZnF contains
three lysine (K) residues (KNRRKSCQACRLRK), each
possessing a -amino group slightly more basic (pKa
10.5) than their -amino group (pKa 9.1) [22], we
investigated whether these moieties might be suscepti-
ble to alkylation by IAA at increased pH. As shown in
the inset to Figure 3a, 2 h incubation with excess IAA at
pH 10 produced ions at m/z 1921, 1979, 2037, and 2095,
consistent with (3), (4), (5), and (6) peptide adducts, by
2021J Am Soc Mass Spectrom 2005, 16, 2017–2026 CYSTEINE REACTIVITY IN ER ZINC FINGERScomparison with the (3) adducts formed at pH 7.4.
Thus, under alkaline conditions IAA not only alkylates
all free thiols in ZnF but also its lysine -amino groups.
By comparison with these highly efficient IAA alky-
lations of ZnF thiol and amino groups, BrB and K3
arylation of ZnF were much less effective at pH 7.4 and
37 °C. Figure 3b shows that after BrB treatment, unre-
acted peptide (0) at m/z 1747 remained the major
component along with a slightly lower abundance
signal from the mono-alkylated peptide (1) at m/z 1937;
only a minor proportion of doubly-alkylated peptide
conjugate (2) at m/z 2127 was detectable. Figure 3c
shows that after K3 treatment, similar abundance pro-
files were noted as for BrB treatment. Furthermore, the
K3 MALDI-TOF spectra revealed that instead of detect-
ing only K3 hydroquinone arylation products (each
adding 172 Da to the ZnF molecular mass, as indicated
in Table 1), the isotopic envelopes for mono- and
doubly-arylated conjugates indicated the presence of
both K3 quinone (Q, m/z 1917) and hydroquinone (HQ,
m/z 1919) adducts, as illustrated in the Figure 3c expan-
sion panel for the mono adduct signal. Multiple reac-
tions between K3 and ZnF resulted in variable spectral
ratios of Q:HQ, with Q being the more prevalent
species, particularly when analyzed by LC-ESI-MS,
Figure 3. Representative MALDI-TOF spectra generated from
1 h incubation (pH 7.4, 37 °C) of synthetic peptide ZnF with: (a)
IAA, (b) BrB, and (c) K3. Each reaction gave mono (1) and doubly
(2) alkylated/arylated peptide conjugates. IAA at pH 9, (Figure 3a
inset) gave additional adduct ions for triple (3), quadruple (4),
pentuple (5), and hexatuple (6) conjugates. Incubation of K3 with
ZnF·acm2 with acetamidomethyl-protected thiols gave no aryla-
tion ((c) inset).suggesting that oxidation of the arylated HQ to its Q form was occurring during the sample separation phase
of the analysis. To confirm the thiol specificity of ZnF
arylation by K3, an alternative form of the synthetic ZnF
peptide was used, ZnF·acm2, the same as ZnF except
that the two cysteine thiols are blocked by acetamido-
methyl (acm) groups. Even when this ZnF·acm2 peptide
was incubated with K3 for 3 h at pH 7.4 (37 °C), no
arylation products were observed, as demonstrated by
the unreacted peak (m/z 1889) in the Figure 3c insert.
The conclusion that K3 arylation of ZnF occurs only on
free cysteines at pH 7.4 was further confirmed by
tandem MS mass spectrometry (see below). However,
as seen with IAA under alkaline conditions, a low
abundance K3 peak likely representing arylation of the
N-terminal -amino group was detected (data not
shown).
The observed degree of reactivity for the various ZnF
alkylating reagents was IAA  BrB  K3, graphically
demonstrated by the Figure 4 time course profiles
showing disappearance of unreacted peptide measured
by MALDI-TOF. By carrying out the reactions at differ-
ent pH, it was also observed that nucleophilic attack by
IAA and BrB occurred more rapidly at higher pH,
consistent with their dependence on thiolate anions.
Assuming pseudo first-order reactions (suggested by
the linearity of semilog plots of Figure 4 data) and mono
adduct formation on ZnF, approximate rate constants
were calculated for each reagent as shown in Table 2.
Figure 4. Time course profiles for disappearance of unreacted
ZnF in reactions with IAA, BrB, and K3. The unreacted peptide ion
peak heights (monoisotopic) are expressed as a percentage of the
total peak heights for the unreacted, mono, and doubly-
conjugated peptide ions in each MALDI-TOF spectrum.
Table 2. Pseudo first order rate constants (min1) for the rate
of disappearance of unreacted peptide upon incubation with
excess reagent at 37 °C
pH IAA BrB K3
2.8 0.4  102 0.5  102 5.5  102
7.4 7.2  102 2.0  102 2.2  102
2 2 29.0 21.9  10 3.4  10 0.1  10
m M
2022 ATSRIKU ET AL. J Am Soc Mass Spectrom 2005, 16, 2017–2026Apparent from this table are the near 50-fold more
rapid IAA reaction rate at pH 9 relative to pH 2.8 and
the 7-fold more rapid rate for BrB at alkaline pH, in
contrast to the K3 Michael addition reaction which
proceeded 50-fold slower at alkaline pH.
Although IAA rapidly reacts with both cysteine
residues in ZnF, the major products resulting from BrB
or K3 reactions were single adducts. Since cysteine
residues might be differentially reactive, the BrB and K3
adducted ZnF structures were probed by tandem MS.
Figure 5 shows LC-ESI-MS/MS spectra from the 5
charge states of the BrB (Figure 5a, precursor ion m/z
388.2) or K3 (Figure 5b, precursor ion m/z 384.2) mono-
alkylated ZnF. Analogous spectra recorded for other
charge states (not shown) were comparable but re-
vealed some additional fragment ions. Confirmatory
MALDI-TOF/TOF tandemMS were also obtained (data
not shown). Since BrB and K3 reactions could be
specific to Cys-237, Cys-240, a mixture of both thiols,
and also a fraction of N-terminal -amino groups, a
table of calculated fragment masses was constructed to
account for each possible structure and to interrogate
the MS/MS spectra for the presence of these peaks.
Table 3 includes all fragment ions observed by LC-ESI-
MS/MS, including those with various charge states; all
sequence fragment ions (b and y) detected following
BrB and K3 reactions are shown in the fragmentation
schemes in Figure 5a and b. The masses of fragment
ions that were formed by cleavage between the two
Figure 5. Examples of LC-ESI-MS/MS spectra
substituted by BrB: spectrum from precursor ion
from precursor ion 384.2 (5). The schematic c
charge states studied by LC-ESI-MS/MS and frocysteine residues, such as the abundant ions y6 and y7,allowed the location of the BrB and K3 modifications to
be determined unambiguously. No fragment ions were
observed that could be unique to modification of the
N-terminus or Cys-237, whereas strong ions were found
that were unique to modifications involving Cys-240.
Thus, the tandem MS data excluded the possibility of
any N-terminal reactions by either BrB or K3, and
demonstrated that mono-adduction by both reagents
targeted Cys-240 to the exclusion of Cys-237.
MS Analysis of Full-Length (67 kDa) ER
Treatment and MS analysis of recombinant ER protein
followed a previously described double enzyme (Lys-C
and Asp-N) digestion protocol [19] designed to separate
components of each ER zinc finger, as shown in Figure
1. Figure 6 shows the resulting MALDI-TOF peptide
mass fingerprints from untreated (Figure 6a), IAA
treated (Figure 6b), BrB treated (Figure 6c), and K3
treated (Figure 6d) ER. As is common with MALDI
analysis of unseparated digests, many potentially sig-
nificant peptides were not observed. Nevertheless, the
spectrum from untreated ER resulted in 42% sequence
coverage when searched against the SwissProt data-
base, peaks ascribed to predicted ER peptides being
indicated with asterisks, including the abundant diag-
nostic ZnF2B peptide at m/z 1064.5 (Figure 6a). Alkyla-
tion of ER by IAA produced both the mono- and
doubly-alkylated conjugates of ZnF2B at m/z 1122.6 and
ono-arylated synthetic peptide ZnF. (a) Mono-
88.2 (5). (b) Mono-substituted by K3: spectrum
ge diagrams combine fragmentations from all
ALDI-TOF/TOF spectra.of m
m/z 3
leava1180.6, respectively (Figure 6b). ER treatment with BrB
2023J Am Soc Mass Spectrom 2005, 16, 2017–2026 CYSTEINE REACTIVITY IN ER ZINC FINGERSTable 3. Combined LC-ESI-MS/MS data derived from 4 and 5 precursor ions for synthetic peptide ZnF singly arylated by BrB
or K3. Calculated Mr’s for modification at cysteine residues corresponding to Cys-237 and Cys-240 of ER are compared with derived
Mr’s based on experimentally observed m/z values and charge states (z). ND  peak not detectable above noise level
Ion type Calc. Mr
Cys-237-BrB
obs. m/z (z) Derived Mr Calc. Mr
Cys-240-BrB
obs. m/z (z) Derived Mr
y4 571.382 286.70 (2) 571.38 571.382 286.70 (2) 571.39
y4-NH3 554.365 278.18 (2) 554.34 554.365 278.19 (2) 554.37
y5 674.401 ND ND 864.475 433.23 (2) 864.48
b5-NH3 665.408 333.70 (2) 665.38 665.408 333.70 (2) 665.39
y6 745.438 ND ND 935.512 468.76 (2) 935.51
y6-NH3 728.411 ND ND 918.485 919.48 (2) 918.47
y7 873.497 ND ND 1063.571 532.81 (2) 1063.59
y7-NH3 856.470 ND ND 1046.544 524.30 (2) 1046.59
b7-H2O 1044.540 ND ND 854.466 428.24 (2) 854.47
y13-H2O 1789.946 1791.00 1790.00 1789.946 448.50 (4) 1789.99
b13-NH3 1772.911 444.23 (4) 1772.88 1772.911 444.23 (4) 1772.95
Cys-237-K3 Cys-240-K3
y4 571.382 286.70 (2) 571.38 571.382 286.70 (2) 571.39
y4-NH3 554.365 278.18 (2) 554.34 554.365 278.19 (2) 554.37
b5-NH3 665.408 333.70 (2) 665.38 665.408 333.70 (2) 665.39
y6 746.438 ND ND 915.475 458.72 (2) 915.48
y7 873.497 ND ND 1043.540 522.78 (2) 1043.56
y7-NH3 856.470 ND ND 1026.507 514.78 (2) 1026.56
b7-H2O 1024.502 ND ND 854.466 428.24 (2) 854.48
b10-H2O 1326.607 663.35 (2) 1324.68 1326.607 663.35 (2) 1326.70
y13-H2O 1769.904 443.49 (2) 884.96 1769.904 443.49 (2) 1769.96
a13 1741.909 436.49 (4) 1741.92 1741.909 436.49 (4) 1741.96Figure 6. MALDI-TOF peptide mass fingerprints of Lys-C and Asp-N digested ER, either untreated
or previously alkylated or arylated. (a) Untreated ER: m/z 1064.5 represents unmodified ZnF2B. (b)
IAA-treated ER: m/z 1122.6 and 1180.6 represent mono (1) and doubly (2) alkylated ZnF2B. (c)
BrB-treated ER: m/z 1254.7 and 1444.7 represent mono (1) and doubly (2) arylated ZnF2B. (d)
K3-treated ER: m/z 1404.6 and 1406.6 represent doubly-arylated ZnF2B quinone (2Q) and quinone/
hydroquinone (Q/HQ). Peaks marked with asterisks correspond to other ER peptides.
2024 ATSRIKU ET AL. J Am Soc Mass Spectrom 2005, 16, 2017–2026also produced mono- and doubly-alkylated conjugates
of ZnF2B, detected at m/z 1254.6 and 1444.7, respec-
tively (Figure 6c). In contrast, ER treatment with K3
produced only doubly-arylated adducts of ZnF2B, cor-
responding to ions at m/z 1404.6 and 1406.6, and repre-
senting the Q and HQ states of arylated K3, respectively
(Figure 6d). In a separate experiment, LC-ESI-MS anal-
ysis of the K3 treated sample demonstrated the exis-
tence of both the mono- and doubly-arylated conjugates
of ZnF2B (data not shown).
As with the synthetic ZnF peptide substrate, the
presence of unmodified ZnF2B peptide ions (m/z 1064.6)
in the MALDI-TOF spectra shown in Figure 6c and d
indicated that chemical modification of full-length ER
by BrB and K3 was incomplete and generally proceeded
at a slower rate than IAA alkylation. LC-ESI-MS/MS of
the doubly-conjugated ZnF2B present in the same di-
gests was performed to confirm that the modifications
were specific to cysteine residues. In no treatment
condition was there any fragment ions detected to
suggest chemical conjugation to residues other than
cysteines. As shown in Figure 7 for IAA (Panel a), BrB
(Panel b), and K3 (Panel c) treatments, the observed N-
and C-terminal fragment ions revealed conjugation to
both Cys-237 and Cys-240. For example, compared with
ZnF2B from unreacted ER (not shown), the reaction
product from BrB produced an increase of 190 Da
between y3/y6 ions as well as b2/b3 and a characteristic
increase of 380 Da for the b8 and y8 fragment ions
(Figure 7b). Similarly for K3, a consistent increment of
170 Da between y3/y6 and a2/b3 ions and 340 Da
between y7/y8 confirmed the presence of modifications
Figure 7. LC-ESI-MS/MS CID product ion mas
ions derived from in vitro chemical modification
(a) Doubly IAA-alkylated ion of m/z 394.2. (b)
K3-arylated ion of m/z 468.8.to both cysteine residues (Figure 7c).Discussion
Bromobimane fluorescence provides a sensitive tool for
protein detection following modification of Cys thiol
groups. Our results demonstrate that this fluorescence
can also provide an overall picture of cysteine oxida-
tion, as only those Cys residues having free thiols are
accessible to react with BrB. However, fluorescence
provides only a general picture, devoid of information
about the status of individual cysteine residues. This is
a particular problem in evaluating the oxidation status
of the ER-DBD as only 8 of the 13 cysteine residues in
ER play a role in zinc binding. Consequently, it was
important to develop more specific methods to probe
the sensitivity of individual cysteine thiols to covalent
modifications produced by chemical agents capable of
impairing ER DNA-binding function.
The strong nucleophilic character of the cysteine
residue derives from thiol deprotonation to form the
thiolate anion, the pKa of which may range from 6.0 to
8.5, depending on the local charge environment of the
cysteine residue [23, 24]. Thus, under more basic con-
ditions, deprotonation of thiols to form thiolates is
enhanced, consistent with the enhanced alkylation rate
of the ZnF peptide to IAA and BrB (Table 2). The
reaction of each cysteine thiolate with IAA or BrB
typifies a bimolecular nucleophilic substitution reaction
(SN2). For such reactions that involve halogen leaving
groups, the rate of reaction is affected to a large extent
by the electronegativity of the leaving group as well as
the bond strength between the halogen and the carbon
atom of the alkyl/aryl group, giving rise to the follow-
ctra of doubly-conjugated ZnF2B triply-charged
R followed by digestion with Lys-C and Asp-N:
bly BrB-arylated ion of m/z 482.2, (c) Doublys spe
of E
Douing order of reactivity for the halides: I  Br  Cl
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reactivity (3.5-fold) observed between IAA and BrB,
although steric factors must also be taken into consid-
eration. The bulkier BrB alkylator is expected to react
more slowly than IAA.
Although N-terminal and -amino groups may serve
as potential targets in Michael addition reactions at pH
 8, at physiological pH the Michael type reactivity of
amines is almost an order of magnitude slower than
thiols [25]. These previous observations are consistent
with our present findings, showing that at physiological
pH, the primary Michael addition targets of K3 in ZnF
are its cysteine residues. In contrast to the more rapid
reactivity of the halogenated reagents under basic con-
ditions, K3 addition occurred more rapidly under acidic
conditions (Table 2). Higher K3 reactivity at low pH can
partly be explained by the availability of protons to
interact (H-bond) with a negatively charged K3 car-
bonyl oxygen, effectively increasing the relative posi-
tive charge at the meta-position of the quinone and
acceptor site of cysteine attack. Furthermore, under
acidic conditions, the cysteine thiol is fully protonated
and nucleophilic addition reaction is driven by the
available electron pair on the sulphur atom. Conse-
quently, the protonated thiol form of cysteine may serve
as the preferred nucleophile relative to the thiolate that
is the predominant species occurring under basic con-
ditions. This is in contrast to previous reports which
indicated that in Michael-type reactions, thiolates (S)
rather than thiols (SH) are the generally preferred
nucleophiles [23–25]. However, our observed K3 reac-
tion kinetics are consistent with an earlier study show-
ing that protonated cysteine thiols are reactive to Mi-
chael acceptors having an , unsaturated carbonyl
system, such as K3 [26].
It is notable that MALDI-TOF was better able than
LC-ESI-MS to discriminate between the Q and HQ
states of K3 conjugates on either ZnF or recombinant
ER. Thus, an LC-ESI-based analysis is not appropriate
for an accurate determination of the HQ:Q conjugate
ratios, even though such ratios may be biologically
significant. From this point of view, MALDI would be
the preferred choice for monitoring HQ:Q conjugates.
Furthermore, tandem studies carried out by MALDI-
TOF/TOF also proved to be effective for structural
analysis of the peptides.
The present study also draws attention to the fact
that the two cysteine thiols within ZnF2B are not
chemically equivalent. Cys-240 is flanked on either side
by Ala-239 and Arg-241, whereas Cys-237 is sand-
wiched between Ser-236 and Gln-238 (Figure 1). Neigh-
boring amino acids can determine thiol pKa and, thus,
the chemical reactivity of an entire protein, as has been
shown for the active enzymatic site of thioredoxin in
which nearby Asp carboxyl and Lys amino groups
influence local thiol pKa and thereby influence the rate
of thiol disulfide reactions at physiological pH [27].
Based on tandem-MS fragmentation experiments with
mono-conjugated ZnF peptide, we observed that Cys-240 is much more reactive than Cys-237. Unlike the first
zinc finger of ER, which contains only three basic
residues, the second zinc finger contains eight basic
residues, all in its C-terminal region (Figure 1). Conse-
quently, thiols within the second zinc finger would be
expected to have lower pKa and to be more reactive
than their counterparts in the first zinc finger, possibly
contributing to the observed greater reactivity of the ER
second zinc finger to K3 and other thiol targeting
reagents. Based on this primary structure consideration,
future studies might focus on specific cysteine residues
other than those involved in zinc binding that are
similarly flanked by basic residues (e.g., Cys-245, Cys-
530), as these might also be preferred targets for elec-
trophilic attack.
Conclusions
As stated earlier, the primary goal of the present study
was to develop and optimize a mass spectrometry
based technique to fingerprint covalent changes occur-
ring in the zinc fingers of human ER protein. The use of
a model peptide with amino acid sequence that spans
the C-terminal portion of the second zinc finger facili-
tated the development and optimization of effective
mass spectrometric protocols. MALDI-TOF and LC-
ESI-MS proved valuable for the detection and charac-
terization of selected chemical modifications within the
labile second zinc finger of full-length recombinant ER
protein. The use of tandem-MS techniques allowed the
specific locations of the chemical modifications to be
identified, thus paving the way for an atomic under-
standing of how various oxidants actually deform ER.
The results presented here confirm that basic amino
acid residues can affect the pKa and, consequently, the
reactivity of zinc finger thiols to electrophilic reagents.
There are substantial difficulties in extrapolating in
vitro studies on recombinant protein to the analysis of
complex samples from human tissue. Nevertheless, it is
anticipated that the resulting expertise that has been
developed for characterizing potential chemical modi-
fications to cysteine thiol groups in the ER-DBD will
facilitate the cataloging of in vivo chemical modifica-
tions occurring in the endogenously overexpressed ER
of human breast tumors.
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